Home/MediWound/Moria Kwiat
MK

Moria Kwiat

Vice President, Regulatory Affairs

MediWound

MediWound Pipeline

DrugIndicationPhase
NexoBridEschar removal in deep partial- and full-thickness thermal burnsApproved
EscharExDebridement of chronic and other hard-to-heal wounds (e.g., venous leg ulcers)Phase 2
MW005Treatment of non-melanoma skin cancersPre-clinical